Provided by Tiger Trade Technology Pte. Ltd.

Whitehawk Therapeutics, Inc.

4.09
+0.02000.49%
Post-market: 4.090.00000.00%16:10 EDT
Volume:142.33K
Turnover:576.54K
Market Cap:233.17M
PE:-3.67
High:4.11
Open:4.06
Low:3.96
Close:4.07
52wk High:5.50
52wk Low:1.81
Shares:57.01M
Float Shares:28.74M
Volume Ratio:0.34
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1137
EPS(LYR):-0.3328
ROE:-44.98%
ROA:-28.70%
PB:1.27
PE(LYR):-12.29

Loading ...

Whitehawk Therapeutics presents PTK7 data at WCLC 2026

TIPRANKS
·
Sep 14

Whitehawk Says PTK7 Expression Stays Stable After Standard Care in EGFR Wild-Type Nsclc, Supporting HWK-007 ADC Targetability

Reuters
·
Sep 14

Whitehawk Therapeutics Director Vijay K Iyengar Files Initial Beneficial Ownership Statement

Reuters
·
Sep 12

WhiteHawk Therapeutics Appoints Vijay Iyengar, Md, to Board of Directors

THOMSON REUTERS
·
Sep 11

Press Release: Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors

Dow Jones
·
Sep 11

Whitehawk Therapeutics Joins Morgan Stanley Global Healthcare Conference Fireside Chat

Reuters
·
Sep 02

TD Cowen Remains a Hold on Whitehawk Therapeutics (WHWK)

TIPRANKS
·
Aug 07

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 07

Whitehawk Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Whitehawk Therapeutics Posts Corporate Deck Highlighting ADC Platform and Phase 1 Pipeline Progress

Reuters
·
Aug 06

Whitehawk Q2 FY26 Net Loss Narrows to $16.64 Million

Reuters
·
Aug 06

WhiteHawk Therapeutics Inc Q2 Operating Expenses USD 18.109 Million

THOMSON REUTERS
·
Aug 06

Press Release: Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Dow Jones
·
Aug 06

Whitehawk Therapeutics Inc Expected to Post a Loss of 30 Cents a Share - Earnings Preview

Reuters
·
Aug 03

Biocytogen, Whitehawk Therapeutics Team up on Bispecific Antibody-drug Conjugate Development

Reuters
·
Jul 07

Biocytogen and Whitehawk Therapeutics Enter Global Collaboration for Bispecific Antibody ADC Development

THOMSON REUTERS
·
Jul 07

Whitehawk Therapeutics Inc: Additional Financial Terms were not Disclosed

THOMSON REUTERS
·
Jul 07

Whitehawk Therapeutics - Biocytogen to Receive Upfront Payment, Milestone Payments, and Low Single-digit Royalties

THOMSON REUTERS
·
Jul 07

Whitehawk Therapeutics Initiated at Buy by B. Riley Securities

Dow Jones
·
Jun 25

Whitehawk Therapeutics Inc : B. Riley Initiates Coverage with Buy Rating; Target Price $10

THOMSON REUTERS
·
Jun 25